KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Treasury Shares (2016 - 2025)

CRISPR Therapeutics AG (CRSP) has disclosed Treasury Shares for 8 consecutive years, with $60000.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 3.23% to $60000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $60000.0 through Dec 2025, down 3.23% year-over-year, with the annual reading at $60000.0 for FY2025, 3.23% down from the prior year.
  • Treasury Shares hit $2.0 million in Q4 2025 for CRISPR Therapeutics AG, down from $2.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.4 million in Q4 2024 to a low of $170316.0 in Q4 2023.
  • Historically, Treasury Shares has averaged $987388.3 across 5 years, with a median of $1.0 million in 2021.
  • Biggest five-year swings in Treasury Shares: changed 0.0% in 2021 and later dropped 3.23% in 2025.
  • Year by year, Treasury Shares stood at $63000.0 in 2021, then changed by 0.0% to $63000.0 in 2022, then fell by 1.59% to $62000.0 in 2023, then changed by 0.0% to $62000.0 in 2024, then dropped by 3.23% to $60000.0 in 2025.
  • Business Quant data shows Treasury Shares for CRSP at $60000.0 in Q4 2025, $60000.0 in Q3 2025, and $62000.0 in Q2 2025.